I. S. Noskova
I. S. Noskova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
A. N. Ilnitskiy
Research Medical Center «Gerontology
1 shared publication- E. M. Saitova
9th Medical and Diagnostic Center of the Ministry of Defense of Russia; Libre Diagnostic Center
1 shared publication - E. S. Kravchenko
Sverdlovsk Regional Clinical Psychoneurological Hospital for War Veterans
1 shared publication - E. V. Vaevskaya
Research Medical Center «Gerontology
1 shared publication - Irina P. Pochitaeva
Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia
1 shared publication - K. S. Korenevich
Karat Clinic
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 9,p. 37-42
Evaluation of the impact of nutritional correction using the biologically active food supplement “Zinc chelate” in preventive programs aimed at increasing individual viability
Zinc has been shown to have a positive effect on recovery from pneumonia, colds, and diarrhea. There is also evidence of a link between low zinc levels and the severity of the novel coronavirus infection, leading to active study of its use as a non-specific prophylaxis and adjuvant therapy for COVID-19. The most pronounced effect of zinc supplementation is expected in individuals with subclinical or severe zinc deficiency. Due to the high incidence of zinc deficiency and its significant contribution to a wide range of pathologies, zinc deficiency correction is an economically feasible intervention. Nutrition correction using the Zinc Chelate dietary supplement increases resistance to acute respiratory viral infections, alleviates their course, and improves the convalescence period; improvement of the immune locus of the vital domain of intrinsic viability has pleiotropic effects on the aesthetic domain of intrinsic viability.
- 1 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 9,p. 37-42
Open AccessEvaluation of the impact of nutritional correction using the biologically active food supplement “Zinc chelate” in preventive programs aimed at increasing individual viability
Zinc has been shown to have a positive effect on recovery from pneumonia, colds, and diarrhea. There is also evidence of a link between low zinc levels and the severity of the novel coronavirus infection, leading to active study of its use as a non-specific prophylaxis and adjuvant therapy for COVID-19. The most pronounced effect of zinc supplementation is expected in individuals with subclinical or severe zinc deficiency. Due to the high incidence of zinc deficiency and its significant contribution to a wide range of pathologies, zinc deficiency correction is an economically feasible intervention. Nutrition correction using the Zinc Chelate dietary supplement increases resistance to acute respiratory viral infections, alleviates their course, and improves the convalescence period; improvement of the immune locus of the vital domain of intrinsic viability has pleiotropic effects on the aesthetic domain of intrinsic viability.